GlaxoSmithKline PLC Director/PDMR Shareholding (3911A)

TIDMGSK

RNS Number : 3911A

GlaxoSmithKline PLC

23 March 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ====================================================================== 
 a)   Name                     Dr K Slaoui 
===  ========================  ============================================ 
 b)   Position/status          PCA of Dr M M Slaoui (Chairman, Global 
                                Vaccines) 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  ============================================ 
 b)   Nature of the            An increase of 4 ADSs following the notional 
       transaction              allocation of ADSs on 22 March 2017, at 
                                a price of $42.28 per ADS, as a result 
                                of the revaluation of the cash element 
                                of the notional investment held within 
                                the GSK 401(K) plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $42.28     4 
                                 ---------  ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2017-03-22 
===  ========================  ============================================ 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQXLFLDXFEBBZ

(END) Dow Jones Newswires

March 23, 2017 12:55 ET (16:55 GMT)